Delhi Chief Minister Arvind Kejriwal on Sunday said that approval for the emergency use of two "made in India" vaccines will give a positive direction to the country's fight against coronavirus.
Congratulating the countrymen, Kejriwal saluted the scientists and doctors for the achievement.
The Drugs Controller General of India (DCGI)on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.
"Congratulations to all the countrymen.Approval by DCGI to emergency use of two made in India vaccines will give a positive direction to the country's fight against corona. Salute to the scientists and doctors whose hard work helped us reach here," Kejriwal tweeted in Hindi.
The approval was granted by the DCGI following the recommendation by the COVID-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
This paves the way for the roll-out of at least two vaccines in India in the coming days and a massive inoculation drive against the coronavirus that has claimed over 1.49 lakh lives in the country.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.